Evaluation of the bio-rad geenius HIV 1/2 assay as part of a confirmatory HIV testing strategy for Quebec, Canada: Comparison with western blot and inno-lia assays

2Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The rapid confirmatory Bio-Rad Geenius HIV 1/2 assay was evaluated as an alternative to the HIV-1 Western blot (WB) confirmatory assay. A total of 370 retrospective samples collected from 356 patients were tested. Sensitivity of the Geenius assay to detect HIV-1 and HIV-2 infections was 100% and 97%, respectively, and that of the WB assay was 86% and 39%, respectively. Geenius reduced the number of indeterminate results by 85% and exhibited a differentiation capacity for HIV-1 and HIV-2 of 100% and 89%, respectively. Three of 10 patients presenting with an early HIV infection (1 to 2 weeks before seroconversion by WB) were positive using Geenius. None of the HIV-negative samples were positive using Geenius or WB. However, 7% and 10% of them were indeterminate with Geenius and WB, respectively, leading to a specificity rate of 93% for Geenius and 90% for WB. Ninety cadaveric samples (54 negative, 23 HIV-1 positive, and 3 HIV-1 indeterminate) were tested with Geenius, leading to a sensitivity of 100%, a specificity of 96%, and an indeterminate rate of 4%. Our results indicate that the Bio-Rad Geenius HIV 1/2 rapid test exhibits better sensitivity to detect HIV-1 infections and better performance than WB to confirm and differentiate between HIV-1 and HIV-2 infections. The performance of this new confirmatory assay to detect early infections, to reduce the rate of indeterminate status, and to confirm HIV-1 infection in cadaveric blood samples makes Geenius a potent reliable alternative to the WB.

Author supplied keywords

Cite

CITATION STYLE

APA

Serhir, B., Desjardins, C., Doualla-Bell, F., Simard, M., Tremblay, C., & Longtin, J. (2019). Evaluation of the bio-rad geenius HIV 1/2 assay as part of a confirmatory HIV testing strategy for Quebec, Canada: Comparison with western blot and inno-lia assays. Journal of Clinical Microbiology, 57(6). https://doi.org/10.1128/JCM.01398-18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free